Gregory J. Flesher
Overview
Gregory J. Flesher received an average of $2M in total compensation, including $366K in salary, at Reneo Pharmaceuticals from 2020 to 2022. Gregory Flesher also received an average of $917K at Tokai Pharmaceuticals from 2017 to 2019.
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
Reneo PharmaceuticalsPresident and Chief Executive Officer
Reneo PharmaceuticalsChief Executive Officer and President
Reneo PharmaceuticalsChief Executive Officer and President
Tokai PharmaceuticalsChief Executive Officer
Tokai PharmaceuticalsChief Executive Officer
Tokai PharmaceuticalsChief Executive Officer
Source: SEC filings on April 26, 2023, April 22, 2022, March 31, 2020, May 15, 2019, and April 30, 2018.
Related executives
We found 14 more executives who work or worked at Reneo Pharmaceuticals and Tokai Pharmaceuticals.
Ashley Hall
Reneo Pharmaceuticals
Chief Development Officer
Michael Cruse
Reneo Pharmaceuticals
Chief Operating Officer
Paul Little
Tokai Pharmaceuticals
Chief Financial Officer
Vineet Jindal
Reneo Pharmaceuticals
Chief Financial Officer
Bryan Smith
Tokai Pharmaceuticals
General Counsel
David-Alexandre Gros
Tokai Pharmaceuticals
Chief Executive Officer
Catherine Turkel
Tokai Pharmaceuticals
President
Jon Kuwahara
Tokai Pharmaceuticals
Senior Vice President of Finance and Administration
News
Reneo Pharmaceuticals CEO Gregory Flesher's 2022 pay falls 78% to $1.2M
April 26, 2023
Reneo Pharmaceuticals CEO Gregory Flesher's 2021 pay jumps 3,939% to $5.4M
April 22, 2022
Tokai Pharmaceuticals CEO Gregory Flesher's 2019 pay slips 11% to $843K
March 31, 2020
Tokai Pharmaceuticals CEO Gregory Flesher's 2018 pay slips 2% to $943K
May 15, 2019